Missouri Resumes Use of Johnson & Johnson Vaccine

From: KTLO/Associated Press

Missouri is resuming use of the Johnson & Johnson COVID-19 vaccine after federal scientific advisers decided its benefits outweigh a rare risk of blood clots.

The state made the announcement Friday night in a tweet in response to U.S. health officials lifting an 11-day pause on the single-dose vaccine.

The state said that providers with J&J vaccine in stock can immediately begin administering it and that shipments from the federal government will resume next week. Just over 105,000 doses of J&J had been administered in Missouri before the pause.

The federal government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died, and seven remain hospitalized.

But ultimately, federal health officials decided that J&J’s one-and-done vaccine is critical to fight the pandemic – and that the small clot risk could be handled with warnings to help younger women decide if they should use that shot or an alternative.

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on linkedin
LinkedIn
On Key

Related Posts

%d bloggers like this: